EB researcher observing sample material in a lab.

Funding excellent research

Aiming for a life without EB

EB-ResNet supports and coordinates research funding on behalf of its member patient organisations and partners. We currently offer three funding schemes: Research grants through scheduled calls for proposals, Ad-hoc grants our flexible funding scheme, and co-funding for industry-partnering projects.

EB-ResNet welcomes proposals for innovative research and clinical development of treatments or diagnostics. All proposals are evaluated for scientific excellence, feasibility and value for money, and whether they address the priority needs of people with EB. We undertake peer review to ensure that only the best research is funded.

Our funding schemes. How do your ideas fit in?

Research grants (next call opens 7 June 2021)	Ad-hoc grants (closed)	Industry co-funding (open)
You are engaged in fundamental to preclinical research or clinical trials in EB Your project idea falls within the scope of a current research call (all priorities call or special call in spring and/or autumn) You are working in academia, or in a clinic (cooperation with industry welcome) Your project objectives can be achieved in 6 to 36 months and financed with up to EUR 90,000.00 p.a.	You are engaged in fundamental research to preclinical or clinical trials in EB You are in need of quick funding or additional funding (co-funding option) to respond to an arising opportunity in fundamental to preclinical research or proof of concept project You are working in academia, in a clinic or in industry Your project can be undertaken within one year (renewable if results are promising) and financed with up to EUR 100,000.00 p.a.	You are engaged in translational research and undertaking clinical trials in EB Your project is in late preclinical to clinical stage You are working in the industry and/or in cooperation with academia The project needs additional funding of up to EUR 250,000.00 to be realised